Latest press releases
- US appeals court issues a temporary injunction pending appeal against distribution of generic PULMICORT RESPULES® (budesonide inhalation suspension)
- 24 May 2013
- Results from Phase III studies of naloxegol for treatment of opioid-induced constipation presented at Digestive Disease Week 2013
- 21 May 2013
- Assessing your asthma is key to taking control
- 13 May 2013
- AstraZeneca PLC first quarter results 2013
- 25 April 2013
- US District Court rules one PULMICORT RESPULES® (budesonide inhalation suspension) patent invalid and another patent not infringed
- 1 April 2013
- AstraZeneca settles litigation over CRESTOR patent
- 25 March 2013
- AstraZeneca to establish strategic R&D center in Gaithersburg, Md; Wilmington remains North America commercial headquarters
- 18 March 2013
- US Court of Appeals affirms decision finding SEROQUEL XR formulation patent valid and infringed
- 14 February 2013
- AstraZeneca encourages atherosclerosis education among high risk patients during American Heart Month
- 14 February 2013
AstraZeneca tweets
-
AZ is committed to finding innovative ways to help mental health patients. Find out more at http://t.co/BqpVJt98Xu #MHM2013
23 May -
Have you met Beverly Sweetwater and Daniel Learningsworth yet? Visit booth 833 and say hello #APAAM13 http://t.co/qJj3XiAkWD...
23 May -
RT @ConnectCVHealth: AstraZeneca HealthCare Foundation applauds @PHealthySchools 4 improving #CVHealth via healthy lunches & exercise http:…
22 May -
May is Mental Health Month - as a caregiver it’s also important to keep a healthy lifestyle http://t.co/dNFSm6IWcW #MHM2013
22 May -
These interactive maps show which pharmacies are open in OKC area http://t.co/6gAh216zY1 #Tornado #Oklahoma
21 May